[go: up one dir, main page]

FI875427L - Menetelmä valmistaa hevosen -interferonia - Google Patents

Menetelmä valmistaa hevosen -interferonia Download PDF

Info

Publication number
FI875427L
FI875427L FI875427A FI875427A FI875427L FI 875427 L FI875427 L FI 875427L FI 875427 A FI875427 A FI 875427A FI 875427 A FI875427 A FI 875427A FI 875427 L FI875427 L FI 875427L
Authority
FI
Finland
Prior art keywords
preparing
equine interferon
interferon
preparing equine
equine
Prior art date
Application number
FI875427A
Other languages
English (en)
Swedish (sv)
Other versions
FI99116B (fi
FI875427A0 (fi
FI99116C (fi
Inventor
Rudolf Hauptmann
Adolf Himmler
Peter Swetly
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of FI875427A0 publication Critical patent/FI875427A0/fi
Publication of FI875427L publication Critical patent/FI875427L/fi
Publication of FI99116B publication Critical patent/FI99116B/fi
Application granted granted Critical
Publication of FI99116C publication Critical patent/FI99116C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/57IFN-gamma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI875427A 1986-12-10 1987-12-10 Menetelmä valmistaa hevosen -interferonia FI99116C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863642096 DE3642096A1 (de) 1986-12-10 1986-12-10 Pferde-(gamma)-interferon
DE3642096 1986-12-10

Publications (4)

Publication Number Publication Date
FI875427A0 FI875427A0 (fi) 1987-12-10
FI875427L true FI875427L (fi) 1988-06-11
FI99116B FI99116B (fi) 1997-06-30
FI99116C FI99116C (fi) 1997-10-10

Family

ID=6315829

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875427A FI99116C (fi) 1986-12-10 1987-12-10 Menetelmä valmistaa hevosen -interferonia

Country Status (20)

Country Link
US (1) US5602010A (fi)
EP (1) EP0271824B1 (fi)
JP (3) JPS63233794A (fi)
KR (1) KR880007568A (fi)
AT (1) ATE91722T1 (fi)
AU (1) AU616873B2 (fi)
CA (1) CA1339776C (fi)
DE (2) DE3642096A1 (fi)
DK (1) DK170054B1 (fi)
ES (1) ES2058094T3 (fi)
FI (1) FI99116C (fi)
HU (1) HU213566B (fi)
IE (1) IE60404B1 (fi)
IL (1) IL84780A (fi)
NO (1) NO180239C (fi)
NZ (1) NZ222856A (fi)
PH (1) PH30889A (fi)
PT (1) PT86332B (fi)
SU (1) SU1701114A3 (fi)
ZA (1) ZA879245B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN156128B (fi) 1980-04-03 1985-05-18 Biogen Nv
US5272263A (en) 1989-04-28 1993-12-21 Biogen, Inc. DNA sequences encoding vascular cell adhesion molecules (VCAMS)
US6307025B1 (en) 1989-04-28 2001-10-23 Biogen, Inc. VCAM fusion proteins and DNA coding therefor
US7049102B1 (en) 1989-09-22 2006-05-23 Board Of Trustees Of Leland Stanford University Multi-gene expression profile
GB2291645A (en) * 1994-07-21 1996-01-31 Q One Biotech Ltd Equine gamma-interferon
GB9414752D0 (en) * 1994-07-21 1994-09-07 Q One Biotech Ltd Feline gamma-interferon
WO2002036072A2 (en) * 2000-11-03 2002-05-10 Biomedicines, Inc. Method for short-term and long-term drug dosimetry
ATE481135T1 (de) * 2001-11-09 2010-10-15 Intarcia Therapeutics Inc Kombinationstherapie mit omega-interferon zur behandlung von hepatitis c virus oder gelbfieber virus infektionen
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US8052996B2 (en) 2005-02-03 2011-11-08 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
PT2359808E (pt) 2006-08-09 2013-08-28 Intarcia Therapeutics Inc Sistemas de entrega osmótica e montagens de pistão
PL2157967T3 (pl) 2007-04-23 2013-06-28 Intarcia Therapeutics Inc Formulacje zawiesinowe peptydów insulinotropowych i ich zastosowania
CA2726861C (en) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
HUE035862T2 (en) 2009-09-28 2018-05-28 Intarcia Therapeutics Inc Rapid establishment and/or termination of substantial steady-state drug delivery
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
MX2017015504A (es) 2015-06-03 2018-05-15 Intarcia Therapeutics Inc Sistemas de colocacion y remoción de implante.
CA3024479A1 (en) 2016-05-16 2017-11-23 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
CN110225762A (zh) 2017-01-03 2019-09-10 因塔西亚制药公司 包括glp-1受体激动剂的连续施用和药物的共同施用的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE88622C (fi) *
ZA811368B (en) * 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
ZA831094B (en) * 1982-02-22 1983-11-30 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
JPS60118196A (ja) * 1983-11-30 1985-06-25 Takeda Chem Ind Ltd インタ−フェロンの製造法
US4666865A (en) * 1984-01-13 1987-05-19 Centocor, Inc. Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
DE3414831A1 (de) * 1984-04-19 1985-10-31 Hoechst Ag, 6230 Frankfurt Herstellung von polypeptiden mit human-gammainterferon-aktivitaet
FI90990C (fi) * 1984-12-18 1994-04-25 Boehringer Ingelheim Int Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
US4689224A (en) * 1985-10-07 1987-08-25 Neogen Corporation Method for administering vaccines containing equine leukokines and compositions therefor
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
CA1340698C (en) * 1986-07-25 1999-08-10 Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo Preparation and uses of interferon-gamma
US4908432A (en) * 1987-01-09 1990-03-13 New York University Novel polypeptide having gamma-interferon activity

Also Published As

Publication number Publication date
FI99116B (fi) 1997-06-30
DE3642096A1 (de) 1988-06-16
EP0271824B1 (de) 1993-07-21
DK645887D0 (da) 1987-12-09
CA1339776C (en) 1998-03-24
US5602010A (en) 1997-02-11
JPS63233794A (ja) 1988-09-29
HU213566B (en) 1997-08-28
PT86332A (de) 1988-01-01
IL84780A (en) 1992-11-15
KR880007568A (ko) 1988-08-27
DK645887A (da) 1988-06-11
ATE91722T1 (de) 1993-08-15
SU1701114A3 (ru) 1991-12-23
NZ222856A (en) 1991-11-26
NO875136D0 (no) 1987-12-09
IE60404B1 (en) 1994-07-13
NO180239B (no) 1996-12-02
EP0271824A3 (en) 1989-05-24
PT86332B (pt) 1990-11-07
AU616873B2 (en) 1991-11-14
PH30889A (en) 1997-12-23
FI875427A0 (fi) 1987-12-10
DK170054B1 (da) 1995-05-08
JPH07258294A (ja) 1995-10-09
NO180239C (no) 1997-03-12
ZA879245B (en) 1989-08-30
NO875136L (no) 1988-06-13
ES2058094T3 (es) 1994-11-01
IE873342L (en) 1988-06-10
IL84780A0 (en) 1988-05-31
HUT46066A (en) 1988-09-28
FI99116C (fi) 1997-10-10
AU8223387A (en) 1988-06-30
JPH07250690A (ja) 1995-10-03
DE3786649D1 (de) 1993-08-26
EP0271824A2 (de) 1988-06-22

Similar Documents

Publication Publication Date Title
FI875427L (fi) Menetelmä valmistaa hevosen -interferonia
FI883783L (fi) Menetelmä nasaalivalmisteiden valmistamiseksi
KR870700635A (ko) 인터페론의 정제방법
FI981380L (fi) Menetelmä HCV-polypeptidien valmistamiseksi
FI870903L (fi) Menetelmä terapeuttisesti aktiivisten alfa-heterosykleillä substituoitujen tolunitriilien valmistamiseksi
FI874787A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten nor-statiini- ja nor-syklostatiinipolypeptidien valmistamiseksi
FI864560L (fi) Menetelmä uusien insuliinijohdannaisten valmistamiseksi
FI874593L (fi) Menetelmä kinapriilin stabiloimiseksi
FI891711L (fi) Menetelmä diorganodialkoksisilaanien valmistamiseksi
KR870009861A (ko) 수지에 대한 인쇄방법
FI871670L (fi) Menetelmä osseiini-hydroksiapatiittiyhdisteen valmistamiseksi
FI871522L (fi) Menetelmä proteiinien renaturoimiseksi
FI885880L (fi) Menetelmä virusvastaisen yhdisteen valmistamiseksi
FI891677L (fi) Menetelmä 4-demetoksidaunomysinonin valmistamiseksi
KR860004922A (ko) N-포르밀-α-아스파르틸페닐알라닌의 제조방법
KR880001562A (ko) 알킬페놀류의 제조방법
FI874789L (fi) Menetelmä valmistaa farmakologisesti aktiivisia substituoituja 1H-imidatsoleja
KR880701819A (ko) 연료 개량 방법
KR880004732A (ko) 본딩방법
FI880103L (fi) Menetelmä terapeuttisesti aktiivisen sialosyylikolesterolin valmistamiseksi
KR870001175A (ko) 5-치환된-6-아미노피리미딘 유도체의 제조방법
DK388787D0 (da) Fremgangsmaade til fremstilling af interferon
KR880701704A (ko) 알킬렌 또는 링-결합 화합물의 제조방법
FI885045L (fi) Menetelmä polynukleotidien valmistamiseksi
KR860005812A (ko) 4,4-디알킬-2-아제티디논의 제조 방법

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH